ArticleJournal of neuro-oncology2018

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.

Michael J Ciesielski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.